GlaxoSmithKline and Merck KGaA announced a joint decision to terminate their global collaboration on bintrafusp alfa, effective September 30, 2021. Bintrafusp alfa is an investigational bifunctional fusion protein…
Although Florida represents among the worst, if not the most severely hit of states in this most recent Delta variant-driven surge, the Biden administration recently…
While Australia’s drug regulator, Therapeutic Goods Administration (TGA), recently all but banned ivermectin—declaring that General practitioners could not prescribe the drug off-label to treat early-onset COVID-19,…
The Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates of neutralizing antibody responses, in line with those measured in people who have…
Two major European pharmaceutical manufacturers, France-based Sanofi and UK-based GlaxoSmithKline (GSK) found setbacks toward the end of 2020 with an investigational vaccine product as the…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
